Please find enclosed the outcome of the Board Meeting
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Boston Bio Systems Limited's board met on September 4, 2025 and approved several key items. The statutory auditor M/s Nahar V & Company resigned due to pre-occupation in other assignments, and M/s Sunit M Chhatbar & Co. has been appointed to fill the casual vacancy, with a proposal to retain them for a 5-year term subject to shareholder approval at the 30th AGM. The board approved an alteration in the object clause of the Memorandum of Association to add new business areas including IT/software, agriculture, real estate development, and e-commerce/trading. The company also adopted a new set of MOA and AOA to align with the Companies Act, 2013. Additionally, the board approved the Board Report and Annual Report for FY ended March 31, 2025, and the notice for the 30th Annual General Meeting.
The change in auditors is routine and not indicative of any concerns, as the outgoing auditor confirmed no other material reasons for resignation. The expansion of business objects signals a potential diversification beyond the company's current core activities, which shareholders will need to evaluate at the upcoming AGM.